CRK and cancer: However, we found a number of established drivers of cancer progression and invasion (e.g., mTOR, STAT1/5, RHOC, ARF6, HMGB, and CRK) with increased expression levels as well as known suppressors (e.g., AIFL1 and SLIT3) with decreased expression levels upon PTEN inhibition.